Masimo Corporation (NASDAQ:MASI) Given Average Recommendation of “Hold” by Analysts

Masimo Corporation (NASDAQ:MASI) has earned an average recommendation of “Hold” from the nine ratings firms that are covering the company, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold recommendation. The average 12 month price target among brokerages that have covered the stock in the last year is $180.40.

MASI has been the subject of a number of research reports. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. Wolfe Research lowered shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. BTIG Research lowered shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a report on Tuesday, February 17th. Finally, Weiss Ratings upgraded shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a report on Wednesday, May 6th.

Masimo Trading Up 0.0%

Shares of NASDAQ:MASI opened at $179.95 on Wednesday. The firm has a fifty day moving average of $178.56 and a two-hundred day moving average of $159.94. The firm has a market capitalization of $9.42 billion, a P/E ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. Masimo has a 12-month low of $125.94 and a 12-month high of $179.99. The company has a quick ratio of 1.45, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of MASI. Royal Bank of Canada raised its holdings in shares of Masimo by 44.5% during the 1st quarter. Royal Bank of Canada now owns 43,884 shares of the medical equipment provider’s stock valued at $7,311,000 after purchasing an additional 13,513 shares in the last quarter. AQR Capital Management LLC raised its holdings in shares of Masimo by 136.5% during the 1st quarter. AQR Capital Management LLC now owns 8,142 shares of the medical equipment provider’s stock valued at $1,305,000 after purchasing an additional 4,700 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Masimo by 0.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider’s stock valued at $1,894,000 after purchasing an additional 66 shares in the last quarter. Dynamic Technology Lab Private Ltd bought a new position in shares of Masimo during the 1st quarter valued at $220,000. Finally, Jones Financial Companies Lllp raised its holdings in shares of Masimo by 1,267.1% during the 1st quarter. Jones Financial Companies Lllp now owns 2,201 shares of the medical equipment provider’s stock valued at $367,000 after purchasing an additional 2,040 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.